Investors are currently facing concerns over inflation and the uncertainty surrounding Federal Reserve rate cuts, resulting in turbulent markets. However, amidst this volatility, long-term investors can benefit from the stock research provided by Wall Street analysts. One of the top picks by analysts is workplace management software maker Monday.com (MNDY). The company recently reported impressive
Rare
Finance leaders of the Group of Seven (G7) advanced nations met recently in Stresa, Italy, and reaffirmed their commitment to warning against excessively volatile currency moves. This language is seen as a signal to Japan that they have the green light to intervene in the market to prevent rapid falls in the yen. However, despite
Recently, Johnson & Johnson announced a settlement of $6.5 billion to resolve almost all of the lawsuits filed against the company in the U.S. concerning ovarian cancer caused by its talc-based products. This settlement has been a long time coming, as the legal battles have been ongoing for decades, causing financial and public relations difficulties
The Food and Drug Administration’s recent announcement approving Pfizer’s treatment for hemophilia B marks a significant milestone in the field of gene therapy. The drug, known as Beqvez, is the first gene therapy from Pfizer to receive clearance in the U.S., offering new hope for adults with moderate to severe hemophilia B. Beqvez is a
Walgreens recently announced its plans to partner directly with drugmakers to provide cell and gene therapies to patients in the United States. This initiative is part of a broader expansion of the company’s specialty pharmacy services. The establishment of a new business unit dedicated to the specialty pharmacy segment, which includes AllianceRx as a subsidiary,
Looking for rare and lucrative online income streams? Discover innovative platforms and untapped market niches that will revolutionize your digital entrepreneurship journey.